| Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes S Sharif, GA Arreaza, P Zucker, QS Mi, J Sondhi, OV Naidenko, ... Nature medicine 7 (9), 1057-1062, 2001 | 758 | 2001 |
| MicroRNA-mediated control of oligodendrocyte differentiation X Zhao, X He, X Han, Y Yu, F Ye, Y Chen, TN Hoang, X Xu, QS Mi, M Xin, ... Neuron 65 (5), 612-626, 2010 | 559 | 2010 |
| Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis RK Srivastava, QS Mi, JM Hardwick, DL Longo Proceedings of the National Academy of Sciences 96 (7), 3775-3780, 1999 | 434 | 1999 |
| ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis N Pabla, S Huang, QS Mi, R Daniel, Z Dong Journal of Biological Chemistry 283 (10), 6572-6583, 2008 | 356 | 2008 |
| Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases M Weiland, XH Gao, L Zhou, QS Mi RNA biology 9 (6), 850-859, 2012 | 343 | 2012 |
| Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants Y Jin, G Andersen, D Yorgov, TM Ferrara, S Ben, KM Brownson, ... Nature genetics 48 (11), 1418-1424, 2016 | 310 | 2016 |
| Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury Q Wei, K Bhatt, HZ He, QS Mi, VH Haase, Z Dong Journal of the American Society of Nephrology 21 (5), 756-761, 2010 | 261 | 2010 |
| Evaluation of clinical results, histological architecture, and collagen expression following treatment of mature burn scars with a fractional carbon dioxide laser DM Ozog, A Liu, ML Chaffins, AH Ormsby, EF Fincher, LK Chipps, QS Mi, ... JAMA dermatology 149 (1), 50-57, 2013 | 227 | 2013 |
| microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles K Bhatt, QS Mi, Z Dong American Journal of Physiology-Renal Physiology 300 (3), F602-F610, 2011 | 213 | 2011 |
| Clinical and molecular effects on mature burn scars after treatment with a fractional CO2 laser L Qu, A Liu, L Zhou, C He, PH Grossman, RL Moy, QS Mi, D Ozog Lasers in surgery and medicine 44 (7), 517-524, 2012 | 182 | 2012 |
| The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice MW Hamrick, S Herberg, P Arounleut, HZ He, A Shiver, RQ Qi, L Zhou, ... Biochemical and biophysical research communications 400 (3), 379-383, 2010 | 169 | 2010 |
| Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss KH Ding, ZZ Wang, MW Hamrick, ZB Deng, L Zhou, B Kang, SL Yan, ... Biochemical and biophysical research communications 340 (4), 1091-1097, 2006 | 165 | 2006 |
| MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival K Bhatt, L Zhou, QS Mi, S Huang, JX She, Z Dong Molecular medicine 16, 409-416, 2010 | 163 | 2010 |
| Differential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation DV Chan, HM Gibson, BM Aufiero, AJ Wilson, MS Hafner, QS Mi, ... Genes & Immunity 15 (1), 25-32, 2014 | 155 | 2014 |
| Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice QS Mi, D Ly, SE Lamhamedi-Cherradi, KV Salojin, L Zhou, M Grattan, ... Diabetes 52 (8), 1967-1975, 2003 | 140 | 2003 |
| Age‐related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells W Zhang, G Ou, M Hamrick, W Hill, J Borke, K Wenger, N Chutkan, J Yu, ... Journal of Bone and Mineral Research 23 (7), 1118-1128, 2008 | 136 | 2008 |
| p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease Z Ma, L Li, MJ Livingston, D Zhang, Q Mi, M Zhang, HF Ding, Y Huo, ... The Journal of clinical investigation 130 (9), 5011-5026, 2020 | 134 | 2020 |
| The regulation and function of microRNAs in kidney diseases Q Wei, QS Mi, Z Dong IUBMB life 65 (7), 602-614, 2013 | 133 | 2013 |
| Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+ CD25+ regulatory T cells D Ly, QS Mi, S Hussain, TL Delovitch The Journal of Immunology 177 (6), 3695-3704, 2006 | 126 | 2006 |
| Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells QS Mi, D Ly, P Zucker, M McGarry, TL Delovitch Diabetes 53 (5), 1303-1310, 2004 | 119 | 2004 |
